Real-time index price for S&P 500 ESG (ESG), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Maxim downgraded Gilead (GILD) to Hold from Buy. The stock has appreciated significantly following a pullback in the first half of the year, ...
Revenue exceeded analyst estimates by 7.8%. Earnings per share (EPS) missed analyst estimates by 7.5%. Looking ahead, revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared ...
Leerink Partners analyst Daina Graybosch has maintained their bullish stance on GILD stock, giving a Buy rating yesterday. Daina ...
Investor's Business Daily on MSN5d
Gilead Sprints To A Profit-Taking Zone After Riding Covid Drug To Beat And RaiseGilead stock sprinted to a profit-taking zone Thursday after Gilead Sciences rode its Covid treatment to another beat and ...
Gilead stock surges after Q3 earnings beat estimates and raised FY 2024 guidance, with strong HIV drug sales and analyst ...
Gilead Sciences' Q3 2024 results exceeded expectations, driven by a strong performance of the HIV portfolio. Read why I ...
Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsDaniel O'Day - Chairman, Chief ...
Buying $1000 In GILD: If an investor had bought $1000 of GILD stock 20 years ago, it would be worth $9,878.72 today based on ...
Real-time index price for PHLX Housing Index (HGX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback